科技赋能 盐碱地焕发新“丰”光
齐鲁晚报网· 2025-07-23 22:51
创新破壁,盐碱滩涂崛起"新粮仓"。面对广袤盐碱地的天然制约,东营以科技为犁,开辟出粮食增产的 战略新空间。国家农高区构建协同创新网络,推动盐碱地治理从"改地适种"向"改种适地"的战略转型。 耐盐碱小麦在无灌溉条件下稳产,高蛋白大豆在盐碱土壤中创出高产纪录,这些育种奇迹的背后,是农 业科技对资源边界的勇敢挑战与成功突破。当垦利示范基地依据盐碱梯度精准发展特色种植,昔日"不 毛之地"正蝶变为多元增收的"希望田野"。 体系护航,智慧储粮守护"丰收果实"。确保丰收的粮食颗粒归仓、安全存储,是粮安链条的关键一环。 东营构建的"智慧粮库"系统,以技术创新贯穿收储全流程。"盲检"机制保障公平公正,光伏屋顶实现绿 色低碳储粮,智能传感网络形成"冷心"长效抑虫——这些覆盖收储全流程的硬核保障,为"仓廪实"注入 了科技赋能的时代内涵。从高效便捷的售粮体验到储备粮收储的稳步推进,现代技术让"颗粒归仓"的承 诺更加坚实可靠。 从翻滚的金色麦浪到恒温的智能粮仓,东营大地上的丰收实践,奏响了现代农业发展的强劲乐章。盐碱 地里萌发的新绿与粮仓中的金黄共同证明:筑牢国家粮食安全的根基,关键在于以科技创新突破资源约 束,以系统思维构建全链条保 ...
济南市全力推进药品智慧追溯体系全覆盖
齐鲁晚报网· 2025-07-23 22:51
药品追溯体系建设推进 - 济南市市场监督管理局召开重点药品连锁企业追溯工作推进会 对药品追溯体系建设攻坚进行再动员和部署 目标是实现全市药品智慧追溯体系全覆盖建设 [1] - 会议围绕药品追溯体系展开深入交流 听取重点连锁企业代表关于工作进展 成效 挑战及优化计划的汇报 并探讨实践中的瓶颈与解决方案 [1] 追溯工作实施与监管 - 今年以来济南市市场监督管理局组织多轮督导检查和专题调研 覆盖各级医疗机构和零售药店 重点检查糖尿病 高血压等慢性病常用药 医保高值药品和进口药品 [1] - 执法人员利用"码上稽查"APP筛查非法购销药品风险 确保药品来源合规 实地查看系统对接与扫码操作流程 累计收集实操反馈与优化建议30余条 [1] 追溯体系进展与成效 - 全市药品零售企业及医疗机构有效入驻率均在95%以上 追溯体系从"有形覆盖"向"有效运行"阶段优化升级 [2] - 4家市级试点单位全面完成药品赋码扫码及数据上传 上游出库验证率稳定保持在95%以上 [2] - 高新区试点区域实现227家零售药店和305家医疗机构100%入驻追溯平台 其中100余家零售药店与20余家医疗机构率先达成药品全品种 全过程可追溯 [2] 未来工作方向 - 济南市市场监督管理局将加大技术指导与服务保障力度 针对调研和企业反映的技术难题 提供"点对点"帮扶与解决方案 推动追溯体系高质量建设 [2]
潍坊南下河智慧农港城最新进展:主体已完工,年底具备运营条件
齐鲁晚报网· 2025-07-23 22:51
潍坊南下河新发地经营开发有限公司总经理韩鑫鑫向记者介绍了项目概况:项目总占地面积205亩,建 筑面积31万平方米。主要规划建设内容包括农副产品交易中心、水产品集散中心和冷链智慧物流园 (即"两中心一园区"),并配套商务运营预制菜电商综合体、酒店公寓、办公楼等设施。项目将开发智 慧化交易平台,配套建设冷库及仓储物流配送区,目标是打造一个集农副产品交易、冷链仓储、物流配 送、电商等功能于一体的现代智慧农港城。 创新设计破解传统市场痛点 作为传统农贸市场的升级版,智慧农港城在功能布局上进行了多项创新设计,重点解决了传统市场常见 的交通拥堵、交易效率低等问题。韩鑫鑫详细说明:"项目创新性地采用了'每层皆是首层'的设计理 念。在西北侧设置了专用货车坡道,45吨重卡可直接驶达二层装卸货,小型车辆更可直达屋顶停车场。 同时,内部规划了三级道路系统,设置四个主要出入口,以保障物流车辆高效通行。" 项目建设是经济发展的命脉,也是城市更新的重要引擎。当前,在潍坊南下河智慧农港城建设现场,一 座现代化的农副产品交易中心已拔地而起,未来将成为服务全市乃至辐射全省的重要农产品流通枢纽。 南下河智慧农港城项目选址于原工业区地块,其建设不 ...
Amgen vs. Novo Nordisk: Which Pharma Giant Is the Better Buy?
ZACKS· 2025-07-23 22:51
Key Takeaways Amgen's growth is driven by newer drugs, biosimilars, and its Horizon deal despite looming patent losses. Novo Nordisk leads in GLP-1s, but faces competition, weak CagriSema data and a CEO transition. Amgen offers a stronger valuation and dividend yield, while Novo shows faster projected 2025 EPS growth.Amgen (AMGN) and Novo Nordisk (NVO) are among the largest companies in the pharmaceutical space.Amgen boasts one of the largest portfolios in the sector, with a strong presence in oncology, c ...
Visa Swiping Toward a Beat: Should You Buy Before Q3 Earnings?
ZACKS· 2025-07-23 22:51
Key Takeaways V is expected to post fiscal Q3 EPS and revenues of $2.86 and $9.87B, up 18.2% and 10.9% Y/Y, respectively. V will likely gain from strong growth in payment volumes, processed transactions and cross-border activity. Rising expenses and client incentives over $4B may partially offset Visa's strong volume-driven growth.Visa Inc. (V) is set to report its third-quarter fiscal 2025 results on July 29, 2025, after market close. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings ...
BXP to Post Q2 Earnings: What to Expect From the Stock?
ZACKS· 2025-07-23 22:51
Key Takeaways BXP's Q2 revenues are projected to rise 1.31% year over year to $801 million. Higher interest expenses and lower occupancy may weigh on BXP's Q2 FFO per share. BXP's strategic repositioning in core markets supports stable revenues amid leasing demand.BXP, Inc. (BXP) is slated to report second-quarter 2025 results on July 29, after market close. While the company’s quarterly results are likely to display a year-over-year rise in revenues, funds from operations (FFO) per share are expected to ...
What's in the Cards for Brown & Brown This Earnings Season?
ZACKS· 2025-07-23 22:51
Key Takeaways Core commissions and fees likely rose from organic growth and acquisitions. Profit-sharing contingent commissions expected to grow on better underwriting and business expansion. Net investment income expected to grow to $22.9M , aided by higher interest rates and cash balances.Brown & Brown, Inc. (BRO) is expected to register an improvement in its top and bottom lines when it reports second-quarter 2025 results on July 28, after the closing bell.The Zacks Consensus Estimate for BRO’s second- ...
Hasbro's Q2 Earnings and Revenues Beat Estimates, Stock Up
ZACKS· 2025-07-23 22:51
Key Takeaways HAS reported Q2 EPS of $1.3 and revenues of $980.8M, both topping the consensus mark. Growth in the Wizards segment offset declines in Consumer Products and Entertainment revenues. HAS raised 2025 revenue and EBITDA guidance, citing licensing, games and cost efficiency efforts.Hasbro, Inc. (HAS) reported second-quarter fiscal 2025 results, with earnings and revenues beating the Zacks Consensus Estimate. The top line declined year over year while the bottom line increased from the prior-year' ...
Why Array Technologies, Inc. (ARRY) is a Top Momentum Stock for the Long-Term
ZACKS· 2025-07-23 22:51
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.It also includes access to the Zacks Style Scores. What are the Zacks Style Scores? The Zacks Style Sco ...
Krispy Kreme, GoPro and Beyond Meat shares soar in revival of meme stock craze
New York Post· 2025-07-23 22:50
Shares in a donut chain, camera company and meat-substitute maker surged Wednesday in a revival of meme stocks.Krispy Kreme, the North Carolina-based chain with about 350 shops, soared as much as 25% on Wednesday.GoPro, famous for its miniature action cameras, jumped 49% while Beyond Meat rose 11%. 3 Krispy Kreme Cake Batter donuts on display in a Times Square shop. Stephen YangShares in Opendoor Technologies, an online platform that buys and sells real estate, plummeted 18% after a wild week in trading – ...